HDAC inhibitors are known to exert diverse anticancer effects including apoptosis, cell cycle arrest, and differentiation although the detailed mechanisms of action may be highly varied depending on the types of the inhibitors and cancer cells tested (Falkenberg and Johnstone, 2014). Here, HDAC9 is linked to cancer.